Maturity onset diabetes of the young due to HNF1A variants in Croatia

<h4>Introduction</h4> <p>Maturity onset diabetes of the young due to HNF1A mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults. It is often misdiagnosed as type 1 or type 2 diabetes, but establishing genetic diagnosis is important, as treatment differs...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Pavić, T, Juszczak, A, Pape Medvidović, E, Burrows, C, Šekerija, M, Bennett, A, Ćuća Knežević, J, Gloyn, A, Lauc, G, McCarthy, M, Gornik, O, Owen, K
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: Croatian Society of Medical Biochemistry and Laboratory Medicine 2018
_version_ 1826280657804853248
author Pavić, T
Juszczak, A
Pape Medvidović, E
Burrows, C
Šekerija, M
Bennett, A
Ćuća Knežević, J
Gloyn, A
Lauc, G
McCarthy, M
Gornik, O
Owen, K
author_facet Pavić, T
Juszczak, A
Pape Medvidović, E
Burrows, C
Šekerija, M
Bennett, A
Ćuća Knežević, J
Gloyn, A
Lauc, G
McCarthy, M
Gornik, O
Owen, K
author_sort Pavić, T
collection OXFORD
description <h4>Introduction</h4> <p>Maturity onset diabetes of the young due to HNF1A mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults. It is often misdiagnosed as type 1 or type 2 diabetes, but establishing genetic diagnosis is important, as treatment differs from the common types of diabetes. HNF1A-MODY has not been investigated in Croatia before due to limited access to genetic testing. In this study we aimed to describe the characteristics of young adults diagnosed with diabetes before the age of 45 years, who have rare HNF1A allele variants, and estimate the prevalence of HNF1A-MODY in Croatia.</p> <h4>Materials and methods</h4> <p>We recruited 477 C-peptide positive and beta cell antibody negative subjects through the Croatian Diabetes Registry. HNF1A was sequenced for all participants and systematic assessment of the variants found was performed. The prevalence of HNF1A-MODY was calculated in the study group and results extrapolated to estimate the proportion of diabetic individuals with HNF1A-MODY in Croatia and the population prevalence.</p> <h4>Results</h4> <p>Our study identified 13 individuals harbouring rare HNF1A allelic variants. After systematic assessment, 8 were assigned a diagnosis of HNF1A-MODY. Two individuals were able to discontinue insulin treatment following the diagnosis. We estimated that HNF1A-MODY in Croatia has a prevalence of 66 (95% CI 61 - 72) cases per million.</p> <h4>Conclusions</h4> <p>The estimated prevalence of HNF1A-MODY in Croatia is similar to that reported in other European countries. Finding cases lead to important treatment changes for patients. This strongly supports the introduction of diagnostic genetic testing for monogenic diabetes in Croatia.</p>
first_indexed 2024-03-07T00:17:00Z
format Journal article
id oxford-uuid:7b30ea3c-7c8b-4241-969f-22928cdaac24
institution University of Oxford
language English
last_indexed 2024-03-07T00:17:00Z
publishDate 2018
publisher Croatian Society of Medical Biochemistry and Laboratory Medicine
record_format dspace
spelling oxford-uuid:7b30ea3c-7c8b-4241-969f-22928cdaac242022-03-26T20:49:01ZMaturity onset diabetes of the young due to HNF1A variants in CroatiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7b30ea3c-7c8b-4241-969f-22928cdaac24EnglishSymplectic Elements at OxfordCroatian Society of Medical Biochemistry and Laboratory Medicine2018Pavić, TJuszczak, APape Medvidović, EBurrows, CŠekerija, MBennett, AĆuća Knežević, JGloyn, ALauc, GMcCarthy, MGornik, OOwen, K <h4>Introduction</h4> <p>Maturity onset diabetes of the young due to HNF1A mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults. It is often misdiagnosed as type 1 or type 2 diabetes, but establishing genetic diagnosis is important, as treatment differs from the common types of diabetes. HNF1A-MODY has not been investigated in Croatia before due to limited access to genetic testing. In this study we aimed to describe the characteristics of young adults diagnosed with diabetes before the age of 45 years, who have rare HNF1A allele variants, and estimate the prevalence of HNF1A-MODY in Croatia.</p> <h4>Materials and methods</h4> <p>We recruited 477 C-peptide positive and beta cell antibody negative subjects through the Croatian Diabetes Registry. HNF1A was sequenced for all participants and systematic assessment of the variants found was performed. The prevalence of HNF1A-MODY was calculated in the study group and results extrapolated to estimate the proportion of diabetic individuals with HNF1A-MODY in Croatia and the population prevalence.</p> <h4>Results</h4> <p>Our study identified 13 individuals harbouring rare HNF1A allelic variants. After systematic assessment, 8 were assigned a diagnosis of HNF1A-MODY. Two individuals were able to discontinue insulin treatment following the diagnosis. We estimated that HNF1A-MODY in Croatia has a prevalence of 66 (95% CI 61 - 72) cases per million.</p> <h4>Conclusions</h4> <p>The estimated prevalence of HNF1A-MODY in Croatia is similar to that reported in other European countries. Finding cases lead to important treatment changes for patients. This strongly supports the introduction of diagnostic genetic testing for monogenic diabetes in Croatia.</p>
spellingShingle Pavić, T
Juszczak, A
Pape Medvidović, E
Burrows, C
Šekerija, M
Bennett, A
Ćuća Knežević, J
Gloyn, A
Lauc, G
McCarthy, M
Gornik, O
Owen, K
Maturity onset diabetes of the young due to HNF1A variants in Croatia
title Maturity onset diabetes of the young due to HNF1A variants in Croatia
title_full Maturity onset diabetes of the young due to HNF1A variants in Croatia
title_fullStr Maturity onset diabetes of the young due to HNF1A variants in Croatia
title_full_unstemmed Maturity onset diabetes of the young due to HNF1A variants in Croatia
title_short Maturity onset diabetes of the young due to HNF1A variants in Croatia
title_sort maturity onset diabetes of the young due to hnf1a variants in croatia
work_keys_str_mv AT pavict maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT juszczaka maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT papemedvidovice maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT burrowsc maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT sekerijam maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT bennetta maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT cucaknezevicj maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT gloyna maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT laucg maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT mccarthym maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT gorniko maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia
AT owenk maturityonsetdiabetesoftheyoungduetohnf1avariantsincroatia